LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

Search

Microbot Medical Inc

Затворен

2.36 -1.67

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

2.36

Максимум

2.48

Ключови измерители

By Trading Economics

Приходи

-77K

-3.6M

Служители

20

EBITDA

-79K

-3.6M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+206.12% upside

Дивиденти

By Dow Jones

Следващи печалби

23.03.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

26M

167M

Предишно отваряне

4.03

Предишно затваряне

2.36

Техническа оценка

By Trading Central

Увереност

Neutral Evidence

Microbot Medical Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

6.03.2026 г., 19:32 ч. UTC

Придобивния, сливания и поглъщания

Diana Shipping Increases Offer to Acquire Genco -- Update

6.03.2026 г., 17:44 ч. UTC

Придобивния, сливания и поглъщания

Lonza to Offload Majority Stake in Capsule Business to Lone Star in $2.2 Billion Deal

6.03.2026 г., 22:26 ч. UTC

Значими събития в новините

Why $100 Oil Is Now in Sight. Who Wins, Who Loses. -- Barrons.com

6.03.2026 г., 22:07 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Boeing Says Spirit Acquisition Will Help Improve Safety -- Market Talk

6.03.2026 г., 22:03 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

6.03.2026 г., 22:03 ч. UTC

Пазарно говорене

Boeing CEO's Pay Nears $24 Million During Recovery Phase -- Market Talk

6.03.2026 г., 21:50 ч. UTC

Пазарно говорене
Значими събития в новините

Financial Services Roundup: Market Talk

6.03.2026 г., 21:37 ч. UTC

Печалби

Salesforce Stock Might Not Be an AI Loser After All -- Barrons.com

6.03.2026 г., 21:25 ч. UTC

Значими събития в новините

How The Iran War Impacts Ukraine. -- Barrons.com

6.03.2026 г., 21:17 ч. UTC

Печалби

Burlington Stores' Strong Year Should Lift the Stock. What Comes Next. -- Barrons.com

6.03.2026 г., 20:50 ч. UTC

Печалби

Marvell Stock Pops 20%. Semiconductor Earnings Show AI Demand Is Strong. -- Barrons.com

6.03.2026 г., 20:46 ч. UTC

Печалби

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

6.03.2026 г., 20:31 ч. UTC

Значими събития в новините

Oil Prices Soar Past $90. Trump Demands 'Unconditional Surrender' From Iran -- and Kuwait Cut Production. -- Barrons.com

6.03.2026 г., 20:18 ч. UTC

Пазарно говорене

Oil Makes Record Weekly Gains As Strait of Hormuz Stays Shut -- Market Talk

6.03.2026 г., 20:12 ч. UTC

Пазарно говорене
Значими събития в новините

U.S. Natural Gas Futures Gain on Global Energy Turmoil -- Market Talk

6.03.2026 г., 19:10 ч. UTC

Пазарно говорене
Значими събития в новините

$150 Oil Seen As Realistic If Hormuz Closure Lasts -- Market Talk

6.03.2026 г., 18:54 ч. UTC

Пазарно говорене

Fed's Hammack: Dollar Hasn't Lost Prime Status -- Market Talk

6.03.2026 г., 18:44 ч. UTC

Пазарно говорене
Значими събития в новините

U.S. Oil Rig Count Increases By 4 to 411 -- Market Talk

6.03.2026 г., 18:08 ч. UTC

Печалби

Samsara Stock Jumps 16% After Earnings. Why the CEO Isn't Worried About AI. -- Barrons.com

6.03.2026 г., 18:04 ч. UTC

Печалби

Marvell Stock Surges on Earnings. It's Not Just a Custom AI Chip Story. -- Barrons.com

6.03.2026 г., 18:04 ч. UTC

Печалби

Samsara Stock Jumps 16% After Earnings. Why the CEO Isn't Worried About AI. -- Barrons.com

6.03.2026 г., 17:49 ч. UTC

Пазарно говорене

AI-Driven Picks-And-Shovels Bet Comes With Risks -- Market Talk

6.03.2026 г., 17:46 ч. UTC

Значими събития в новините

Kuwait Cuts Oil Production as Fallout From Iran Conflict Intensifies -- Update

6.03.2026 г., 17:40 ч. UTC

Пазарно говорене
Печалби

Marvell's Long-Term Outlook Well-Received By Investors -- Market Talk

6.03.2026 г., 17:40 ч. UTC

Печалби

Marvell Stock Surges on Earnings. It's Not Just a Custom AI Chip Story. -- Barrons.com

6.03.2026 г., 17:32 ч. UTC

Пазарно говорене
Значими събития в новините

No Quick Solution for Hormuz Shipping as U.S. Oil Tops $90 -- Market Talk

6.03.2026 г., 17:28 ч. UTC

Пазарно говорене
Значими събития в новините

Aluminum Rising as Strait of Hormuz Stays Locked -- Market Talk

6.03.2026 г., 17:20 ч. UTC

Пазарно говорене
Печалби

Auto & Transport Roundup: Market Talk

6.03.2026 г., 17:20 ч. UTC

Пазарно говорене
Значими събития в новините

Basic Materials Roundup: Market Talk

6.03.2026 г., 17:20 ч. UTC

Придобивния, сливания и поглъщания

BlackRock Sticks to Redemption Minimum on Credit Fund, Sends Shares Lower -- WSJ

Сравнение с други в отрасъла

Ценова промяна

Microbot Medical Inc Прогноза

Ценова цел

By TipRanks

206.12% нагоре

12-месечна прогноза

Среден 7.5 USD  206.12%

Висок 12 USD

Нисък 5 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за Microbot Medical Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

3 ratings

3

Купи

0

Задържане

0

Продай

Техническа оценка

By Trading Central

2.52 / 2.57Подкрепа & съпротива

Краткосрочен план

Neutral Evidence

Средносрочен план

Very Strong Bullish Evidence

Дългосрочен план

Weak Bullish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.
help-icon Live chat